Eric Topol

Latest Headlines

Latest Headlines

FierceBiotech believes in storytelling: Check it out

Our readers hunger for context and analysis of major developments in the industry. We work hard to deliver such insights in all of our daily reports. Yet we aim to go deeper into stories with additional feature articles and special reports.

Biotech, pharma warming up to Facebook

With more than 1 billion users plugged in, Facebook has huge potential to have a real impact on science and public health, beyond just a marketing platform for biotech and pharma companies.

New statins study sorts out diabetes risks

For years now, statins, the cholesterol-lowering drugs, have been a major pillar of the drug industry. But a little cloud is forming over the category. Links to muscle injury were already documented, and now there is a growing body of evidence tying their use to the development of diabetes.

Circulating cells signal upcoming heart attack

Heart attacks can be devastating for the family and the patient, and around half of heart attacks or strokes can occur in people who don't seem to have any obvious risk factors.

NIH funnels $533M into translational research work

The Scripps Transitional Research Institute was one of 14 research groups that will gain $533 million from the NIH over five years. The funds are earmarked to speed the development of new